Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating encouraging results in the treatment of type 2 diabetes. This synthetic peptide duplicates the actions of naturally present GLP-1, a https://bookmarkextent.com/story22858186/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes